Harbin Pharmaceutical Group , Ltd. Goodwill

The latest goodwill for 600664.SS is $39M as of June 2026. That compares with $39M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Harbin Pharmaceutical Group , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 600664.SS's goodwill moved from $39M to $39M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Harbin Pharmaceutical Group , Ltd.'s operating scale or balance-sheet position.

A goodwill figure of $39M for 600664.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 600664.SS's goodwill ($39M), review year-over-year change from $39M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.